HIT-Cas9: A CRISPR/Cas9 Genome-Editing Device under Tight and Effective Drug Control

The CRISPR/Cas9 enabled efficient gene editing in an easy and programmable manner. Controlling its activity in greater precision is desired for biomedical research and potential therapeutic translation. Here, we engrafted the CRISPR/Cas9 system with a mutated human estrogen receptor (ER(T2)), which...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Mol Ther Nucleic Acids
Asıl Yazarlar: Zhao, Chen, Zhao, Yingze, Zhang, Jingfang, Lu, Jia, Chen, Li, Zhang, Yue, Ying, Yue, Xu, Junjun, Wei, Shixian, Wang, Yu
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: American Society of Gene & Cell Therapy 2018
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6178243/
https://ncbi.nlm.nih.gov/pubmed/30312845
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.omtn.2018.08.022
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller